Up­dat­ed: Re­silience to cut most staff, sus­pend op­er­a­tions at Mass­a­chu­setts man­u­fac­tur­ing plant

3 years ago
People
Manufacturing

Rare blood dis­or­ders biotech Hemab rais­es $135M, be­gins trek in­to clin­ic

3 years ago
Financing

Lat­est news on two FDA ap­provals; High-pro­file moves for John Reed, Brent Saun­ders, Christi Shaw..; and more

3 years ago
Weekly

FDA clears Tra­vere’s rare kid­ney dis­ease drug, will come with REMS pro­gram

3 years ago
Pharma
FDA+

FDA ap­proves Apel­lis' reti­nal dis­ease drug as com­peti­tor ex­pects Au­gust de­ci­sion

3 years ago
Pharma
FDA+

Dai­ichi Sankyo gets US patent of­fice to restart re­view of Seagen patent

3 years ago
Pharma
Law

Ox­ford Prop­er­ties Group pur­chas­es Re­silience man­u­fac­tur­ing site for $125M

3 years ago
Deals
Pharma

French court over­turns €444M an­titrust fine against Roche, No­var­tis

3 years ago
Pharma
Law

FDA and HHS should im­prove in­sti­tu­tion­al re­view board in­spec­tion prac­tices, GAO says

3 years ago
R&D

FDA's No. 2 on­col­o­gy of­fi­cial de­parts for biotech start­up

3 years ago
People
FDA+

FDA ac­cepts Iver­ic Bio's NDA, grants pri­or­i­ty re­view for GA drug

3 years ago
R&D
FDA+

Mer­ck seeks more ap­provals for in­fec­tious dis­ease drug

3 years ago
R&D
FDA+

Third Rock-backed au­toim­mune biotech turns off the lights

3 years ago
People
R&D

Kite CEO Christi Shaw to de­part Gilead CAR-T unit

3 years ago
People

Mod­er­na boasts 'step for­ward' with PhI­II da­ta on flu vac­cine, but an­a­lysts are not so sure

3 years ago
R&D

FDA gives the OK to Chiesi for treat­ment of ul­tra-rare en­zyme de­fi­cien­cy dis­ease

3 years ago
Pharma
FDA+

Up­dat­ed: Pfiz­er drops half of par­tic­i­pants from Ly­me tri­al af­ter say­ing re­search con­trac­tor broke rules

3 years ago
R&D
Pharma

Au revoir, Sanofi: John Reed dash­es to J&J; Zen­tal­is plucks new COO from GSK

3 years ago
Peer Review

Bio­gen chair­man Pa­padopou­los, who saw com­pa­ny through highs and lows, to re­tire

3 years ago
People
Pharma

UK could al­low rec­i­p­ro­cal drug ap­provals with US FDA as soon as 2024

3 years ago
Pharma
FDA+

Bris­tol My­ers, Pfiz­er team up with bas­ket­ball leg­end Ka­reem Ab­dul-Jab­bar on stroke risk cam­paign

3 years ago
Pharma
Marketing

Sen­ate be­gins quest to de­mys­ti­fy PBM­s' prac­tices as it mulls leg­is­la­tion

3 years ago
Pharma

Putting a twist on tar­get­ed ther­a­py, Vor Bio­phar­ma her­alds proof of con­cept for its gene-edit­ed stem cells

3 years ago
R&D
Cell/Gene Tx

Klick Health adds com­mer­cial ven­ture group for ear­ly-stage biotechs and ‘mod­ern’ health com­pa­nies

3 years ago
Pharma
Marketing
First page Previous page 385386387388389390391 Next page Last page
A service from the Financial Times